To mark World Heart Day 2021, Huawei has revealed today the stroke study and heart health study. This comes as a result of two influential partnerships with top global institutions – the University of Liverpool in the UK and 301 Hospital in China.
These life-changing projects reaffirm Huawei’s commitment to furthering heart health and stroke research. Released on World Heart Day, the results show the important role wearable technologies can play in the early treatment of heart diseases. They also support the notion of home management of chronic disease, which is a potentially life-changing result for millions living with heart health conditions and those who are vulnerable to stroke.
Huawei has worked alongside the University of Liverpool to further its atrial fibrillation and stroke study. The researchers are set to recruit post-stroke patients, using HUAWEI Band 6 to monitor atrial fibrillation. With the University of Liverpool Stroke Study App, Huawei devices can help to monitor how atrial fibrillation, sleep apnoea and habits like walking pace might affect the risk of stroke.
Professor Gregory Lip, from the Liverpool Centre for Cardiovascular Science at the University of Liverpool UK, who is a global expert on atrial fibrillation and stroke, said:
“Atrial fibrillation is the commonest heart rhythm condition, which is associated with a high risk of stroke, heart failure and dementia. We are delighted with this collaborative project using smartwear to help improve detection of this rhythm disorder in people post-stroke. Through our partnership with Huawei, we will see how technology can improve the monitoring of high-risk populations.”